Cancer Nanotechnology: Emerging role of gold nanoconjugates

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 10, 2011, Pages 965-973

  Kudgus, Rachel A ^a   Bhattacharya, Resham ^a   Mukherjee, Priyabrata ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

Cancer; Gold; Nanoparticles; Targeted drug delivery

Indexed keywords

ANTINEOPLASTIC AGENT; AURANOFIN; AUROTHIOGLUCOSE; AUROTHIOMALATE; CETUXIMAB; CISPLATIN; CYT 6091; GEMCITABINE; GOLD NANOPARTICLE; RIDAURO; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER THERAPY; CATALYSIS; CLINICAL TRIAL (TOPIC); DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; IN VIVO STUDY; LIVER TOXICITY; MORBIDITY; MOUTH ULCER; NANOFABRICATION; NANOTECHNOLOGY; NEPHROTOXICITY; PHASE 1 CLINICAL TRIAL (TOPIC); PHOTOTHERAPY; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; TREATMENT PLANNING;

EID: 80055112415     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011797927652     Document Type: Review

References (99)

1. Mukherjee, S., The Emperor of all Maladies - A Biography of Cancer. Scribner: New York, 2010, p 571.
2. Jemal, A.; Siegel, R.; Xu, J.Q.; Ward, E. Cancer Statistics, 2010. Ca-a Cancer J. Clinicians, 2010, 60(5), 277-300.
3. Dhanabal, M.; Jeffers, M.; LaRochelle, W.J. Anti-angiogenic therapy as a cancer treatment paradigm. Curr. Med. Chem. - Anti-Cancer Agents, 2005, 5(2), 115-130.
4. Dolmans, D.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev.Cancer, 2003, 3(5), 380-387.
5. Lee, E.J.; Jameson, J.L. Gene therapy of pituitary diseases. J. Endocrinol., 2005, 185(3), 353-362.
6. Perillo, A.; Ferrandina, G.; Pierelli, L.; Bonanno, G.; Scambia, G.; Mancuso, S. Stem cell-based treatments for gynecological solid tumors. Eur. Rev. Med. Pharmacol. Sci., 2005, 9(2), 93-102.
7. Parveen, S.; Sahoo, S.K. Polymeric nanoparticles for cancer therapy. J. Drug Target., 2008, 16(2), 108-123.
8. Parveen, S.; Sahoo, S.K. Nanomedicine - Clinical applications of polyethylene glycol conjugated proteins and drugs. Clin. Pharmacokinet., 2006, 45(10), 965-988.
9. Das, M.; Mohanty, C.; Sahoo, S.K. Ligand-based targeted therapy for cancer tissue. Exp. Opin. Drug Delivery, 2009, 6(3), 285-304.
10. Larsen, A.K.; Escargueil, A.E.; Skladanowski, A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther., 2000, 85(3), 217-229.
11. Ghosh, P.; Han, G.; De, M.; Kim, C.K.; Rotello, V.M. Gold nanoparticles in delivery applications. Adv. Drug Delivery Rev., 2008, 60(11), 1307-1315.
12. Paciotti, G.F.; Myer, L.; Weinreich, D.; Goia, D.; Pavel, N.; McLaughlin, R.E.; Tamarkin, L. Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery. Drug Delivery, 2004, 11(3), 169-183.
13. Rosi, N.L.; Mirkin, C.A. Nanostructures in biodiagnostics. Chemical Reviews, 2005, 105(4), 1547-1562.
14. El-Sayed, I.H.; Huang, X.H.; El-Sayed, M.A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett., 2006, 239(1), 129-135.
15. Peer, D.; Karp, J.M.; Hong, S.; FaroKhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol., 2007, 2(12), 751-760.
16. Patra, C.R.; Bhattacharya, R.; Wang, E.F.; Katarya, A.; Lau, J.S.; Dutta, S.; Muders, M.; Wang, S.F.; Buhrow, S.A.; Safgren, S.L.; Yaszemski, M.J.; Reid, J.M.; Ames, M.M.; Mukherjee, P.; Mukbopadhyay, D. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res., 2008, 68(6), 1970-1978.
17. Misra, R.; Acharya, S.; Sahoo, S.K. Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discovery Today, 2010, 15(19-20), 842-850.
18. Kim, D.; Jeong, Y.Y.; Jon, S. A Drug-Loaded Aptamer-Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer. ACS Nano, 2010, 4(7), 3689-3696.
19. Oberdorster, G.; Sharp, Z.; Atudorei, V.; Elder, A.; Gelein, R.; Kreyling, W.; Cox, C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol., 2004, 16(6-7), 437-445.
20. Sarin, H.; Kanevsky, A.S.; Wu, H.T.; Brimacombe, K.R.; Fung, S.H.; Sousa, A.A.; Auh, S.; Wilson, C.M.; Sharma, K.; Aronova, M.A.; Leapman, R.D.; Griffiths, G.L.; Hall, M.D. Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J. Translational Med., 2008, 6.
21. Sonavane, G.; Tomoda, K.; Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surf. B-Biointerfaces, 2008, 66(2), 274-280.
22. Connor, E.E.; Mwamuka, J.; Gole, A.; Murphy, C.J.; Wyatt, M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small, 2005, 1(3), 325-327.
23. Bhattacharyya, S.; Bhattacharya, R.; Curley, S.; McNiven, M.A.; Mukherjee, P. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(33), 14541-14546.
24. Daniel, M.C.; Astruc, D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chemical Reviews, 2004, 104(1), 293-346.
25. Murphy, C.J.; Gole, A.M.; Stone, J.W.; Sisco, P.N.; Alkilany, A.M.; Goldsmith, E.C.; Baxter, S.C. Gold Nanoparticles in Biology: Beyond Toxicity to Cellular Imaging. Acc. Chem. Res., 2008, 41(12), 1721-1730.
26. M.A. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc. Chem. Res., 2001, 34(4), 257-264.
27. S.P. Medical Uses of Gold Compounds: Past, Present, and Future. Gold Bull., 1996, 2(29), 53-60.
28. R.V.P.a.S.M. Gold Bulletin, 1987, 20(3).
29. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global Cancer Statistics. Ca-a Cancer J. Clinicians, 2011, 61(2), 69-90.
30. Heath, J.R.; Davis, M.E. Nanotechnology and cancer. Ann. Rev. Med., 2008, 59251-265.
31. Sahoo, S.K.; Parveen, S.; Panda, J.J. The present and future of nanotechnology in human health care. Nanomedicine-Nanotechnol. Biol. and Med., 2007, 3(1), 20-31.
32. Cho, K.J.; Wang, X.; Nie, S.M.; Chen, Z.; Shin, D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res., 2008, 14(5), 1310-1316.
33. Chou, L.Y.T.; Ming, K.; Chan, W.C.W. Strategies for the intracellular delivery of nanoparticles. Chem.Soc. Rev., 2011, 40(1), 233-245.
34. Ross, J.S.; Schenkein, D.P.; Pietrusko, R.; Rolfe, M.; Linette, G.P.; Stec, J.; Stagliano, N.E.; Ginsburg, G.S.; Symmans, W.F.; Pusztai, L.; Hortobagyi, G.N. Targeted therapies for cancer 2004. Am. J.Clin. Pathol., 2004, 122(4), 598-609.
35. Morgillo, F.; Lee, H.Y. Resistance to epidermal growth factor receptor-targeted therapy. Drug Resistance Updates, 2005, 8(5), 298-310.
36. Maeda, H., The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. In Adv. Enzyme Regul., Vol 41, Weber, G., Ed. 2001; Vol. 41, pp 189-207.
37. Noguchi, Y.; Wu, J.; Duncan, R.; Strohalm, J.; Ulbrich, K.; A kaike, T.; Maeda, H. Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Japanese J.Cancer Res., 1998, 89(3), 307-314.
38. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Rel., 2000, 65(1-2), 271-284.
39. H. Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects. Bioconjugate Chem., 2010, 21(5), 797-802.
40. Maeda, H.; Greish, K.; Fang, J., The EPR effect and polymeric drugs: A paradigm shift for cancer chemotherapy in the 21st century. In Polymer Therapeutics Ii: Polymers as Drugs, Conjugates and Gene Delivery Systems, 2006; Vol. 193, pp. 103-121.
41. Allen, T.M. Ligand-targeted therapeutics in anticancer therapy. Nature Reviews Cancer, 2002, 2(10), 750-763.
42. Wang, J.Q.; Sui, M.H.; Fan, W.M. Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics. Curr. Drug Metab., 2010, 11(2), 129-141.
43. Esther, R.J.; Bhattacharya, R.; Ruan, M.; Bolander, M.E.; Mukhopadhyay, D.; Sarkar, G.; Mukherjee, P. Gold Nanoparticles do not Affect the Global Transcriptional Program of Human Umbilical Vein Endothelial Cells: A DNA-Microarray Analysis. J. Biomed. Nanotechnol., 2005, 1(3), 328-335.
44. Goodman, C.M.; McCusker, C.D.; Yilmaz, T.; Rotello, V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjugate Chem., 2004, 15(4), 897-900.
45. Hainfeld, J.F.; Slatkin, D.N.; Focella, T.M.; Smilowitz, H.M. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol., 2006, 79(939), 248-253.
46. Hainfeld, J.F.; Slatkin, D.N.; Smilowitz, H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phy. Med. Biol., 2004, 49(18), N309-N315.
47. Sherman, A.I.; Bonebrake, M.; Allen, W.M. The Application of Radioactive Colloidal Gold in the Treatment of Pelvic Cancer. Am. J. Roentgenol., 1951, 66(4), 624-638.
48. Sherman, A.I.; Terpogossian, M. Lymph-Node Concentration of Radioactive Colloiday Gold Following Interstital Injection. Cancer, 1953, 6(6), 1238-1240.
49. Iyer, A.K.; Khaled, G.; Fang, J.; Maeda, H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Dis. Today, 2006, 11(17-18), 812-818.
50. Bartlett, D.W.; Davis, M.E. Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles. Biotechnol. Bioeng., 2008, 99(4), 975-985.
51. Davis, M.E.; Chen, Z.; Shin, D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Dis., 2008, 7(9), 771-782.
52. Fay, F.; Scott, C.J. Antibody-targeted nanoparticles for cancer therapy. Immunotherapy, 2011, 3(3), 381-394.
53. Stuchinskaya, T.; Moreno, M.; Cook, M.J.; Edwards, D.R.; Russell, D.A. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates. Photochem. Photobiol. Sci., 2011, 10(5), 822-831.
54. Dharap, S.S.; Qiu, B.; Williams, G.C.; Sinko, P.; Stein, S.; Minko, T. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J. Contr.Rel., 2003, 91(1-2), 61-73.
55. Farokhzad, O.C.; Jon, S.Y.; Khademhosseini, A.; Tran, T.N.T.; LaVan, D.A.; Langer, R. Nanopartide-aptamer bioconjugates: A new approach for targeting prostate cancer cells. Cancer Res., 2004, 64(21), 7668-7672.
56. Bhattacharya, R.; Patra, C.R.; Verma, R.; Kumar, S.; Greipp, P.R.; Mukherjee, P. Gold nanoparticles inhibit the proliferation of multiple myeloma cells. Advanced Materials, 2007, 19(5), 711-+.
57. Bhattacharya, R.; Mukherjee, P.; Xiong, Z.; Atala, A.; Soker, S.; Mukhopadhyay, D. Gold nanoparticles inhibit VEGF165- induced proliferation of HUVEC cells. Nano Letters, 2004, 4(12), 2479-2481.
58. Lin, J.Q.; Zhang, H.W.; Chen, Z.; Zheng, Y.G. Penetration of Lipid Membranes by Gold Nanoparticles: Insights into Cellular Uptake, Cytotoxicity, and Their Relationship. Acs Nano, 2010, 4(9), 5421-5429.
59. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.Q.; Thun, M.J. Cancer statistics, 2007. Ca-a Cancer Journal for Clinicians, 2007, 57(1), 43-66.
60. R. Nanoparticle-based Therapeutics in Humans: A Survey. Nanotechnology Law and Business, 2008, 5(2), 135-155.
61. Fischer, N.O.; McIntosh, C.M.; Simard, J.M.; Rotello, V.M. Inhibition of chymotrypsin through surface binding using nanoparticle-based receptors. Proceedings of the Nat. Acad.Sci. USA, 2002, 99(8), 5018-5023.
62. You, C.C.; De, M.; Han, G.; Rotello, V.M. Tunable inhibition and denaturation of alpha-chymotrypsin with amino acid-functionalized gold nanoparticles. J. Am. Chem. Soc., 2005, 127(37), 12873-12881.
63. Giljohann, D.A.; Mirkin, C.A. Drivers of biodiagnostic development. Nature, 2009, 462(7272), 461-464.
64. Chen, W.X.; Bardhan, R.; Bartels, M.; Perez-Torres, C.; Pautler, R.G.; Halas, N.J.; Joshi, A. A Molecularly Targeted Theranostic Probe for Ovarian Cancer. Mol. Cancer Ther., 2010, 9(4), 1028-1038.
65. Bardhan, R.; Chen, W.X.; Bartels, M.; Perez-Torres, C.; Botero, M.F.; McAninch, R.W.; Contreras, A.; Schiff, R.; Pautler, R.G.; Halas, N.J.; Joshi, A. Tracking of Multimodal Therapeutic Nanocomplexes Targeting Breast Cancer in vivo. Nano Lett., 2010, 10(12), 4920-4928.
66. Patra, C.R.; Verma, R.; Kumar, S.; Greipp, P.R.; Mukhopadhyay, D.; Mukherjee, P. Fabrication of Gold Nanoparticle for Potential Application in Multiple Myeloma. J. Biomed. Nanotech., 2008, 4(4), 499-507.
67. Sardar, R.; Funston, A.M.; Mulvaney, P.; Murray, R.W. Gold Nanoparticles: Past, Present, and Future. Langmuir, 2009, 25(24), 13840-13851.
68. Hostetler, M.J.; Templeton, A.C.; Murray, R.W. Dynamics of place-exchange reactions on monolayer-protected gold cluster molecules. Langmuir, 1999, 15(11), 3782-3789.
69. Templeton, A.C.; Hostetler, M.J.; Kraft, C.T.; Murray, R.W. Reactivity of monolayer-protected gold cluster molecules: Steric effects. J. Am. Chem.Soc., 1998, 120(8), 1906-1911.
70. Neely, A.; Perry, C.; Varisli, B.; Singh, A.K.; Arbneshi, T.; Senapati, D.; Kalluri, J.R.; Ray, P.C. Ultrasensitive and Highly Selective Detection of Alzheimer's Disease Biomarker Using Two-Photon Rayleigh Scattering Properties of Gold Nanoparticle. ACS Nano, 2009, 3(9), 2834-2840.
71. Bardhan, R.; Chen, W.X.; Perez-Torres, C.; Bartels, M.; Huschka, R.M.; Zhao, L.L.; Morosan, E.; Pautler, R.G.; Joshi, A.; Halas, N.J. Nanoshells with Targeted Simultaneous Enhancement of Magnetic and Optical Imaging and Photothermal Therapeutic Response. Adv. Function. Mater., 2009, 19(24), 3901-3909.
72. Quinn, J.F.; Raman, R.; Thomas, R.G.; Yurko-Mauro, K.; Nelson, E.B.; Van Dyck, C.; Galvin, J.E.; Emond, J.; Jack, C.R.; Weiner, M.; Shinto, L.; Aisen, P.S. Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease A Randomized Trial. JAMA J. Am. Med. Assoc., 2010, 304(17), 1903-1911.
73. Lu, W.T.; Arumugam, R.; Senapati, D.; Singh, A.K.; Arbneshi, T.; Khan, S.A.; Yu, H.T.; Ray, P.C. Multifunctional Oval-Shaped Gold-Nanoparticle-Based Selective Detection of Breast Cancer Cells Using Simple Colorimetric and Highly Sensitive Two-Photon Scattering Assay. ACS Nano, 2010, 4(3), 1739-1749.
74. Patra, C.R.; Bhattacharya, R.; Mukherjee, P. Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. J. Mater. Chem., 2010, 20(3), 547-554.
75. Huck, W.T.S.; Tien, J.; Whitesides, G.M. Three-dimensional mesoscale self-assembly. J. Am. Chem.Soc., 1998, 120(32), 8267-8268.
76. Mammen, M.; Dahmann, G.; Whitesides, G.M. Effective Inhibitors Of Hemagglutination By Influenza-Virus Synthesized From Polymers Having Active Ester Groups - Insight Into Mechanism Of Inhibition. J. Med.Chem., 1995, 38(21), 4179-4190.
77. Mammen, M.; Choi, S.K.; Whitesides, G.M. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angewandte Chemie-International Edition, 1998, 37(20), 2755-2794.
78. Lee, Y.C.; Lee, R.T. Carbohydrate-Protein Interactions - Basis of Glycobiology. Acco.Chem. Res., 1995, 28(8), 321-327.
79. Kim, D.; Park, S.; Lee, J.H.; Jeong, Y.Y.; Jon, S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo xray computed tomography imaging. J. Am. Chem. Soc., 2007, 129(24), 7661-7665.
80. Han, S.H.; Chang, Y.J.; Jung, E.S.; Kim, J.W.; Na, D.L.; Mook-Jung, I. Effective screen for amyloid beta aggregation inhibitor using amyloid beta-conjugated gold nanoparticles. Int. J. Nanomed., 2011, 12-62.
81. M. Philos. Trans. R. Soc. London, 1857, 147, 145-181.
82. Chen, S.W.; Templeton, A.C.; Murray, R.W. Monolayer-protected cluster growth dynamics. Langmuir, 2000, 16(7), 3543-3548.
83. Brust, M.; Walker, M.; Bethell, D.; Schiffrin, D.J.; Whyman, R. Synthesis Of Thiol-Derivatized Gold Nanoparticles In A 2-Phase Liquid-Liquid System. J. Chem. Society-Chemical Comm., 1994, (7), 801-802.
84. Freeman, R.G.; Grabar, K.C.; Allison, K.J.; Bright, R.M.; Davis, J.A.; Guthrie, A.P.; Hommer, M.B.; Jackson, M.A.; Smith, P.C.; Walter, D.G.; Natan, M.J. Self-Assembled Metal Colloid Monolayers - An Approach to Sers Substrates. Science, 1995, 267(5204), 1629-1632.
85. Grabar, K.C.; Freeman, R.G.; Hommer, M.B.; Natan, M.J. Preparation and Characteration of Au Colloid Monolayers. Ana. Chem., 1995, 67(4), 735-743.
86. Brust, M.; Fink, J.; Bethell, D.; Schiffrin, D.J.; Kiely, C. Synthesis And Reactions Of Functionalized Gold Nanoparticles. J.Chem.Soc. Chem. Comm., 1995, (16), 1655-1656.
87. Qian, H.F.; Zhu, Y.; Jin, R.C. Isolation of Ubiquitous Au-40(SR)(24) Clusters from the 8 kDa Gold Clusters. J. Am. Chem. Soc., 2010, 132(13), 4583-.
88. Lopez-Acevedo, O.; Akola, J.; Whetten, R.L.; Gronbeck, H.; Hakkinen, H. Structure and Bonding in the Ubiquitous Icosahedral Metallic Gold Cluster Au-144(SR)(60). J. Phys.Chem. C, 2009, 113(13), 5035-5038.
89. Fields-Zinna, C.A.; Sardar, R.; Beasley, C.A.; Murray, R.W. Electrospray Ionization Mass Spectrometry of Intrinsically Cationized Nanoparticles, Au-144/146(SC11H22N(CH2CH3)(3)(+)) (x)(S(CH2)(5)CH3)(y) (x+). J. Am. Chem. Soc., 2009, 131(44), 16266-16271.
90. Jadzinsky, P.D.; Calero, G.; Ackerson, C.J.; Bushnell, D.A.; Kornberg, R.D. Structure of a thiol monolayer-protected gold nanoparticle at 1.1 angstrom resolution. Sci., 2007, 318(5849), 430-433.
91. Liu, Y.M.; Tsunoyama, H.; Akita, T.; Tsukuda, T. Efficient and selective epoxidation of styrene with TBHP catalyzed by Au-25 clusters on hydroxyapatite. Chem. Comm., 46(4), 550-552.
92. Qian, H.F.; Eckenhoff, W.T.; Zhu, Y.; Pintauer, T.; Jin, R.C. Total Structure Determination of Thiolate-Protected Au-38 Nanoparticles. J. Am. Chem. Soc., 2010, 132(24), 8280-+.
93. Love, J.C.; Estroff, L.A.; Kriebel, J.K.; Nuzzo, R.G.; Whitesides, G.M. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem. Rev., 2005, 105(4), 1103-1169.
94. Templeton, A.C.; Wuelfing, M.P.; Murray, R.W. Monolayer protected cluster molecules. Acc. Chem.Res., 2000, 33(1), 27-36.
95. Frankamp, B.L.; Boal, A.K.; Rotello, V.M. Controlled interparticle spacing through self-assembly of Au nanoparticles and poly(amidoamine) dendrimers. J. Am. Chem. Soc., 2002, 124(51), 15146-15147.
96. Galow, T.H.; Boal, A.K.; Rotello, V.M. A building block approach to mixed-colloid systems through electrostatic selforganization. Adv. Mater., 2000, 12(8), 576-579.
97. Srivastava, S.; Verma, A.; Frankamp, B.L.; Rotello, V.M. Controlled assembly of protein-nanoparticle composites through protein surface recognition. Adv. Mater., 2005, 17(5), 617-621.
98. Patra, C.R.; Bhattacharya, R.; Mukhopadhyay, D.; Mukherjee, P. Application of gold nanoparticles for targeted therapy in cancer. J. Biomed. Nanotech., 2008, 4(2), 99-132.
99. Libutti, S.K.; Paciotti, G.F.; Byrnes, A.A.; Alexander, H.R.; Gannon, W.E.; Walker, M.; Seidel, G.D.; Yuldasheva, N.; Tamarkin, L. Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine. Clin. Cancer Res., 2010, 16(24), 6139-6149.